DOI: https://doi.org/10.22263/2312-4156.2021.4.67
Novitskaya V.A., Rzheussky S.E.
Tissue sealing medicinal agents group on the pharmaceutical market of the Republic of Belarus
Vitebsk State Order of Peoples’ Friendship Medical University, Vitebsk, Republic of Belarus
Vestnik VGMU. 2021;20(4):67-74.
Abstract.
The purpose of this article was to analyze the pharmaceutical market of the tissue sealing agents group of the Republic of Belarus from 2010 to 2018 based on the data presented in the Medmarket database and the State Register of Medicines of the Republic of Belarus of UE «Center of Expertise and Testing in Healthcare». The group of tissue sealing agents (B02F) was found to be characterized by high growth rates and a relatively large market share. During the studied period, it was represented on the Belarusian pharmaceutical market by only one drug – Tachocomb (manufactured by Takeda Pharmaceutical Company Limited, Japan). When analyzing its dynamics in the period from 2010 to 2018 it was found that, in general, the change in the volume of the market for tissue sealing agents correlates with the change in the volume of the total market for hemostatic drugs over the years. During 2010-2018 there is an increase in the volume of sales for this local sealant, both in monetary (by 1.51) and in natural (by 2.01) expressions with a gradual fall of the price. It has been concluded that the development of the tissue sealing agents by domestic manufacturers is urgent and expedient.
Key words: local hemostatic drugs, tissue sealing agents, Tachocomb, market analysis.
References
1. Davydenko VV, Vlasov TD, Dobroskok IN, Brazhnikova EN, Zabivalova NM. Comparative efficacy of local application hemostatic agents in stopping experimental parenchymal and arterial bleeding. Vestn Eksperim Klin Khirurgii. 2015;8(2):186-94. (In Russ.)
2. Dambaev GTc, Baikov AN, Semichev EV, Shpisman MN, Aleinik AN, Deneko OI, Bushlanov PS. Intraoperative methods of hemostasis in liver operations. Biul Sibir Meditsiny. 2011;10(4):89-92. (In Russ.)
3. Medushevskaia AI, Rzheusskii SE. Analysis of the range of hemostatic drugs. Vestn Farmatsii. 2018;(4):54-9. (In Russ.)
4. Belozerskaia GG, Shirokova TI, Momot AP, Bychichko DIu, Lempert AR, Kabak VA, i dr. Creation and comprehensive research of new composite hemostatic coatings. Gematologiia Transfuziologiia. 2020;65(S1):121. (In Russ.)
5. Barsukova IuN, Melnikova OA. The state of the pharmaceutical market for hemostatic drugs in the Russian Federation. Vestn Voronezh Gos Un-ta Ser Khimiia Biologiia Farmatsiia. 2017;(1):138-42. (In Russ.)
6. Shchegolev AA, Al-Sabunchi OA, Gvozdik VV, Matushkova OS. Modern approaches to the treatment of patients with portal hypertension syndrome complicated by bleeding from varicose veins of the esophagus. Basic techniques of conservative, endoscopic and endovascular hemostasis. Tactical issues. Consilium medicum Khirurgiia. 2004;(2):21-4. (IN Russ.)
7. Beili DX, Fisher DE. Ensuring hemostasis and control of gingival fluid is a mandatory requirement in modern dentistry. Klin Stomatologiia. 2005;(3):69-73. (In Russ.)
8. Belov IuV, Charchian ER, Salagaev GI. Application of the drug TachoComb in the practice of a cardiovascular surgeon. Kardiologiia Serdech-Sosudistaia Khirurgiia. 2016;(5):82-6. (In Russ.)
9. MedmarketWeb. Available from: http://pharm.by/Home/Index. [Accessed 15th Apr 2020].
10. Registers of UE "Center for Expertise and Testing in Health Care". Available from: https://www.rceth.by/Refbank. [Accessed 12th Jule 2021]. (In Russ.)
11. Goiko KV. BCG matrix: concept, construction and analysis. Akad Pedag Idei Novatsiia Ser Studench Nauch Vestn. 2016;(10):147-55. (In Russ.)
12. Vinokurova AP, Zheksenbaeva AB, Klepandina SA, Mikhailova MM, Sivtceva NV, Kontorusova SS. Strategic Management Decisions: Advantages and Disadvantages of the Boston Consulting Group (BCG) Matrix. Ekonomika i Upravlenie v XXI veke: Tendentsii Razvitiia. 2014;(14):33-6. (In Russ.)
Information about authors:
Novitskaya V.A. – applicant for a Master’s degree of the Chair of Organization & Economy of Pharmacy with the course of the Faculty for Advanced Training & Retraining, Vitebsk State Order of Peoples’ Friendship Medical University;
Rzheussky S.E. – Candidate of Pharmaceutical Sciences, associate professor of the Chair of Management & Marketing of Pharmacy, Vitebsk State Order of Peoples’ Friendship Medical University.
Correspondence address: Republic of Belarus, 210009, Vitebsk, 27 Frunze ave., Vitebsk State Order of Peoples’ Friendship Medical University, Chair of Organization & Economy of Pharmacy with the course of the Faculty for Advanced Training & Retraining E-mail: Этот адрес электронной почты защищён от спам-ботов. У вас должен быть включен JavaScript для просмотра. – Veronika .A. Novitskaya.
